On Wednesday, May 11, 2016, President Obama signed into law the Defend Trade Secrets Act (DTSA). The DTSA is a significant piece of legislation that creates a federal cause of action for misappropriation of trade secrets and provides for enhanced damages for trade secret violations.

But despite its name, the Act also provides immunity for whistleblowers who disclose a company’s trade secrets under certain conditions. We believe that all employers should be aware of this aspect of the DTSA, which we briefly summarize here. More

The Hedge Fund Law Report has published an article by Friedman Kaplan litigation partner Anne Beaumont and litigation associate Nora Bojar discussing the recent ruling in Chanin v. Machcinski.  More

Friedman Kaplan partner Ricardo Solano, Jr. has published an article in Pharmaceutical Compliance Monitor addressing the implications and requirements for success that corporate health care providers should expect should they enter into corporate integrity agreements. More

Earlier this month, a group of professors from Columbia and Harvard Law Schools published a seemingly innocuous scholarly paper titled “The 8-K Trading Gap,” which comes to a startling conclusion: data show that insiders of corporate issuers appear routinely to have access to supranormal profits by purchasing the issuers’ securities during the period between the occurrence of an event reportable on U.S. Securities and Exchange Commission Form 8-K and the filing of the 8-K. More